In reference to Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19

Laryngoscope. 2023 Apr;133(4):E29-E30. doi: 10.1002/lary.30505. Epub 2022 Dec 10.

Luigi Angelo Vaira^{1

2}, Giacomo De Riu¹, Paolo Boscolo-Rizzo³, Claire Hopkins^{4

5}, Jerome R Lechien^{6

7}

¹ Maxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
² Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, Sassari, Italy.
³ Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.
⁴ Department of otorhinolaryngology, King's College, London, UK.
⁵ British Rhinological Society, London, UK.
⁶ Department of Anatomy and Experimental Oncology, Mons School of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium.
⁷ Department of Otolaryngology-Head Neck Surgery, Elsan Polyclinic of Poitiers, Poitiers, France.

Abstract

This is a commentary on the article by Hosseinpoor et al. Laryngoscope, 2022

Keywords: COVID-19; SARS-CoV-2; anosmia; coronavirus; corticosteroids; maxillofacial surgery; olfactory dysfunction; olfactory function; smell.